Changing the prescription status of physiotherapists: Perception of Nigerian physiotherapists
DOI:
https://doi.org/10.34058/njmr.v16i2.75Keywords:
Supplementary prescription, Physiotherapists, Drugs, cost-effectiveness, Analgesics, NSAIDsAbstract
Background: There appears to be a global change in the role of physiotherapists (most especially) in serving as supplementary prescribers of relevant drugs.
Objectives: This study aimed to determine the opinion of physiotherapists on enlistment as supplementary prescribers of drugs, and the classes of drugs they would like to prescribe.
Methods: 102 licensed physiotherapists from 5 purposively selected hospitals participated in the study. A self administered questionnaire was used to collect the data. Data were analyzed using descriptive statistics and Kruskal Wallis test.
Results: Eighty-three physiotherapists (83.8%) wanted to be enlisted as supplementary prescribers and most would like to prescribe analgesics (74.8%), NSAIDS (74.8%) and muscle relaxants (59.2%). Also, 89 respondents (86.4%) supported the enactment of a law that will protect physiotherapists in case of professional litigation. A range of reasons were adduced for desiring to have a change in prescription status and these include effectiveness of clinical practice (77.7%), image improvement (67.0%) and the increased benefit for patients (82.5%). The number of respondents who would like to prescribe Analgesics, NSAIDS and Muscle relaxants were significantly higher than for other classes of drugs (P = 0.001). It was concluded that the majority of physiotherapists would want their status to change to that of supplementary prescribers. Also, most prescribers would like to prescribe analgesics and NSAIDS while a moderate number would like to prescribe muscle relaxants under the protection of an enabling law.
References
• Australian Medical Association, 2012. AMA takes strong stance on non-medical prescribing. Available through: https://ama.com.au/media/ama-takes-strong-stance-non-medical-prescribing [Accessed 29 August, 2013].
• CAIPE, 2002. Inter-professional Education. Available through <http://search.yahoo. com/search; caipe. interprofessional%20knowledge&fr2=sb-top&fr=sfp>. [Accessed 5 March, 2013].
• Chartered Society of Physiotherapy, 2013. Practice guidance for physiotherapist supplementary and/or independent prescribers in the safe use of medicines. (2nd Edition). Available through: . [Accessed 29 August, 2013].
• Courtenay, M. and Griffiths, M. 2010. Independent and supplementary prescribing: an essential guide. . http://eprints.bournemouth.ac.uk/11041/. [Accessed 10 March, 2013].
• Crown Report, 1999. Review of prescribing, supply and administration of medicines. Available at: <http://webarchive.nationalarchives.gov.uk/20130107105354/http: /www. dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4077153.pdf>. [Accessed 28 August, 2013].
• Crown Report, 2000. Supplementary prescribing by nurses, pharmacists, chiropodists/ podiatrists, physiotherapists and radiographers within the NHS in England. A guide for implementation. Available at: <http://www.nursingsa.com/pdf/Office/DH_supp_prescribing.pdf>. [Accessed 8 March, 2013].
• Daily Mail, 2012. British physiotherapists become first in the world to be allowed to prescribe medicines for their patients. Available at: <http://www.dailymail.co.uk/health/article-2178025/British-physiotherapists-world-allowed-prescribe-medicines-patients.html>. [Accessed 9 March, 2013].
• Department of Health, 2005. Supplementary Prescribing by Nurses, Pharmacists, Chiropodists/Podiatrists, Physiotherapists and Radiographers within the NHS in England: A guide for implementation Available at: http://webarchive.nationalarchives.gov.uk/ 20130107105354/http:// www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@ dh/@en/documents/digitalasset/dh_4110033.pdf. [Accessed 25 November, 2013].
• Durrell, S., 1996. Expanding the scope of physiotherapy: clinical physiotherapy specialists in consultants' clinics. Manual Therapy, 1 (4), pp. 210-213.
• Grimmer, K., Kumar, S., Gilbert, A., and Milanese, S., 2002. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Physiotherapists’ use, knowledge, and attitudes. Australian Journal of Physiotherapy, 48, pp. 82-91.
• Konitzer, M., Fischer, G.C., and Doering, T.J. 2003. Movement and its significance: Natural healing physiotherapy and modern pharmacological therapy of osteoporosis in the semantic differential. Forsch Komplementarmed Klass Naturheilkd, 10, pp. 128-136.
• Langridge, J.C. and Moran, C.J. 1984. A comparison of two methods of managing patients suffering from rheumatoid arthritis. Physiotherapy. 70(3), pp. 109–13.
• Magos, T. 2006. Interaction between pharmacotherapy and psychotherapy neurophysiologic basis. Neuropsychopharmacologia Hungarica. 8 (2): pp. 73-78.
• MHPRA, 2013. Supplementary Prescribing. Available at: <http://www.mhra. gov.uk/ Howweregulate/ Medicines/ [Accessed 9 March, 2013].
• Moore, R.A., Tramer, M.R., Carroll, D., Wiffen, P.J., and McQuay, H.J. 1998. Quantitative systematic review of topically applied Non-Steroidal Anti-Inflammatory Drugs. Biomedical Journal, 316, pp. 333-338.
• Olszewski, J., Repetowski, M., and Kuśmierczyk, K. 2007. Comparative assessment of results in cervical vertigo pharmacotherapy vs. physiotherapy treatment. Otolaryngologia Polska, 61(5), pp. 827-830.
• Onigbinde, A.T., Adedoyin, R.A., and Johnson, O.E. 2006. Effect of physiotherapy interventions on pharmacokinetic variables: A preliminary Review, Nigerian Journal of Medical Rehabilitation, 11 (1), pp. 6-9.
• Onigbinde, A.T., Olaogun, M.O.B., and Iroghue, K. 2012. An evaluation of the knowledge level of Nigerian physiotherapists on topical pharmacology. Hong Kong Physiotherapy Journal, 30, pp. 36 – 42.
• Onigbinde, A.T., Bamitale, K.D.S., Olaogun, M.O.B., Makinde, O. O., Adetoogun, G.E., and Odeyemi, E. 2013. Opinion and knowledge of Nigerian physiotherapists on relevance and usefulness of pharmacology education on dosage of topical medications. International Journal of Pharmacy and Pharmacology, 2 (1), pp. 55 – 63.
• Zafonte R.D. and Munun M.C. 2001. Phenol and alcohol blocks for the treatment of spasticity; Physical Medicine and Rehabilitation Clinics of North America, 12, pp. 817-832.
